Our Pipeline
Harnessing the immune system to achieve deep and durable clinical responses in cancer
Leveraging our proprietary platform, Xilio is advancing a deep pipeline of novel clinical and preclinical immunotherapies designed to achieve tumor-selective activation.
Metastatic Microsatellite Stable Colorectal Cancer
Advanced Solid Tumors
Advanced Solid Tumors 2
Prostate
Gastric, Pancreatic, Esophageal, Lung
Prostate, Lung, Colorectal
Discovery
IND-enabling
Phase 1
Phase 2
Phase 3
Metastatic Microsatellite Stable Colorectal Cancer
Advanced Solid Tumors
Advanced Solid Tumors 2
Prostate
Gastric, Pancreatic, Esophageal, Lung
Prostate, Lung, Colorectal